Aura Biosciences, Inc. (AURA) Reports In-Line Q2 EPS

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.47), in-line with the analyst estimate of ($0.47).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Trump highlights ibogaine development push, Psyence BioMed responds
• Baxter raises tender offer cap to $600M for senior notes